ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.73
0.23%
US Tech 100
21,198.40
1.36%
S&P 500
6,040.04
1.10%
US Dollar vs CAD
1.43655
0.02%
Bitcoin
98,134.73
-0.55%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Bny Mellon DRN (BONY34) Share Price

Bny Mellon DRN

Bny Mellon DRN (BONY34)

BOV
477.99
5.99
(1.27%)
Closed December 25 2:55PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
477.99
Bid
0.00
Ask
0.00
Volume
11
477.99 Day's Range 477.99
249.50 52 Week Range 503.12
Market Cap
367.609B
Previous Close
472.00
Open
477.99
Last Trade
7
@
477.99
Last Trade Time
Financial Volume
R$ 5,258
VWAP
477.99
Average Volume (3m)
114
Shares Outstanding
769,073,000
Dividend Yield
2.21%
PE Ratio
19.67
Earnings Per Share (EPS)
3.97
Revenue
16.71B
Net Profit
3.05B

About Bny Mellon DRN

Sector
State Commercial Banks
Industry
National Commercial Banks - Non Islamic
Website
www.bnymellon.com
Headquarters
New York, New York, USA
Founded
2007
Bny Mellon DRN is listed in the State Commercial Banks sector of the Brazil Bovespa Exchange with ticker BONY34. The last closing price for Bny Mellon DRN was R$472. Over the last year, Bny Mellon DRN shares have traded in a share price range of R$ 249.50 to R$ 503.12.

Bny Mellon DRN currently has 769,073,000 shares outstanding. The market capitalization of Bny Mellon DRN is R$363 billion. Bny Mellon DRN has a price to earnings ratio (PE ratio) of 19.67.

Ask ADVFN Intelligence (AI)

BONY34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.45-0.716600199402481.44483.14450.7340478.223375DR
415.223.28889080969462.77503.12450.7392481.36808266DR
1287.9922.5615384615390503.12385.32114447.42492669DR
26158.6349.6712174349319.36503.12319.3682421.92917033DR
52227.4990.8143712575250.5503.12249.5159322.43098953DR
156147.6644.7007537917330.33503.12194.4286252.04099524DR
260271.7131.707790004206.29503.12143.65307248.13406954DR

BONY34 - Frequently Asked Questions (FAQ)

What is the current Bny Mellon DRN share price?
The current share price of Bny Mellon DRN is R$ 477.99
How many Bny Mellon DRN shares are in issue?
Bny Mellon DRN has 769,073,000 shares in issue
What is the market cap of Bny Mellon DRN?
The market capitalisation of Bny Mellon DRN is BRL 363B
What is the 1 year trading range for Bny Mellon DRN share price?
Bny Mellon DRN has traded in the range of R$ 249.50 to R$ 503.12 during the past year
What is the PE ratio of Bny Mellon DRN?
The price to earnings ratio of Bny Mellon DRN is 19.67
What is the cash to sales ratio of Bny Mellon DRN?
The cash to sales ratio of Bny Mellon DRN is 3.59
What is the reporting currency for Bny Mellon DRN?
Bny Mellon DRN reports financial results in USD
What is the latest annual turnover for Bny Mellon DRN?
The latest annual turnover of Bny Mellon DRN is USD 16.71B
What is the latest annual profit for Bny Mellon DRN?
The latest annual profit of Bny Mellon DRN is USD 3.05B
What is the registered address of Bny Mellon DRN?
The registered address for Bny Mellon DRN is 225 LIBERTY STREET, NEW YORK, NEW YORK, 10286
What is the Bny Mellon DRN website address?
The website address for Bny Mellon DRN is www.bnymellon.com
Which industry sector does Bny Mellon DRN operate in?
Bny Mellon DRN operates in the NATIONAL COMMERCIAL BANKS - NON ISLAMIC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
COCE11Cia Energetica Ceara Coelce
R$ 1.15
(342.31%)
130k
ESTR4Manufatura Brinquedos Estrela Sa
R$ 4.98
(39.89%)
200
AZEV11Azevedo Travassos Sa
R$ 0.24
(20.00%)
30.4k
OSXB3OSX Brasil SA
R$ 3.80
(11.44%)
2.6k
AMBP3Ambipar Participacoes e Empreendimentos SA
R$ 140.00
(10.24%)
214.9k
TKNO3Tekno Sa Ind Com
R$ 40.70
(-45.73%)
9.8k
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
TKNO4Tekno Sa Ind Com
R$ 55.20
(-20.00%)
7.7k
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
CBEE3Ampla Energia Servicos Sa
R$ 10.01
(-16.58%)
600
HAPV3Hapvida Participacoes Investimento SA
R$ 2.25
(-5.46%)
70.23M
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.86
(0.027137%)
43.79M
ABEV3Ambev SA
R$ 12.22
(-0.08%)
40.18M

Discussion

View Full Feed
firebag1 firebag1 7 minutes ago
Merry Christmas!!!! HMBL will bring us prosperity in 25 and beyond ❤️
HMBL
dia76ca dia76ca 11 minutes ago
1. Developing Deramiocel (Cap-1002) to treat cardiomyopathy in Duchene Muscular Dystrophy (DMD)
2. Cardiomyopathy is much larger than DMD. Beckers next. Then at least half a dozen off-label uses.
3. Expect FDA approval in DMD in 2H 2025.
4. And Cedar-Sinai has a couple more we
ATRA
WizardDomain54 WizardDomain54 12 minutes ago
RE: gitreal
How about re-name to get real, we all know everyone associated with Sidney Resources, names, eMail, address, etc.
but we don't know anything about non-transparent gitreal, why do you suppose? Merry Christmas to all.
SDRC
caddiedad caddiedad 15 minutes ago
Many thanks DMC8 for your links and posts this past year. This particular one sums up Capt Beer’s mantra of “It’s the EPA”, yet again!
It certainly doesn’t hurt for this info to be published Christmas Day in China
AMRN
manibiotech manibiotech 17 minutes ago
So you say . Other side says the same thing .
But you proclaim yourself to be superior . 
Got it . We are just supposed to believe you over everyone else ... just because . 
So you still haven't "honestly " answered the question I asked you 
NWBO
JERSEYHAWG JERSEYHAWG 22 minutes ago
MERRY CHRISTMAS to everyone


🎅
LEHNQ
alertmeipp alertmeipp 23 minutes ago
I agree, at this point, we might as well keep pushing.

Why District Court Decisions Are Often Appealed in Patent Cases
- Patent cases are complex and require interpretation of intricate technical details and legal principles, which district courts may not always get right.
ENTA
jrockents jrockents 23 minutes ago
holyshit were #3 wooooo hooooo!!!! maybe NEXT YEAR????? BLHA HA AH HAH AH AH AHAH A AHA HA HAHAHAHA HA AH HAH AH Ahttps://www.thelion.com/
PHIL
JERSEYHAWG JERSEYHAWG 23 minutes ago
This seems to NEVER END.

I SWEAR...it's forever

😂
LEHNQ
Shawonsarker84 Shawonsarker84 26 minutes ago
Because 99.9% of the trades are done electronically and MM's are the ones that are required to report, little enforcement is needed.
Fails to deliver are electronically-trackable, too. If there were significant fails-to-deliver, then there possibly would be concerns about naked shorting (the
HMBL
Scratchgolf Scratchgolf 26 minutes ago
I don't think he said that. He did make a comment once that news would be out by the first of November back last summer but that time came and passed.
Mean while, Humble does his thing of suppressing negative comments. A sure sign that the company wants to get some buying from the uninformed.
UBQU
baltimorebullet baltimorebullet 27 minutes ago
I think I should start an investment newsletter featuring companies with accepted MAA's.
I know they don't all go on to become commercial successes and there would be plenty of BP drugs in there too, but the smaller biotech's would be wonderful "story stocks" for my readers.
AVXL
Atown62 Atown62 27 minutes ago
*****hhse 2024 year review******

1) Eric lied repeatedly in the blog 

2) Eric lied again and again and again 

3) Eric went to Cannes with NOTHING to show for it as well as the last few years 
HHSE
KIPK KIPK 28 minutes ago
A true theorySLUT paid to post theorySHIT on multiple massage boards..

KARMA in not a theory, Its a selftrap for good...
MGX
RammageRaul RammageRaul 28 minutes ago
Nah only insiders loaded at those cheap prices is why they dropped the fake r/s announcement to spook potential frontloaders when it was trading at 0001/0003
HMBL
drugmanrx drugmanrx 29 minutes ago
Merry Christmas and a Happy Holiday Season to all.

May 2025 be better then 2024 for SNPW

https://i.pinimg.com/originals/34/bf/11/34bf11ebbc032fe5ace99600810064f4.gif
SNPW
TRAPPER JIM TRAPPER JIM 31 minutes ago
Merry Christmas to you too. 
Atown62 Atown62 32 minutes ago
Amazon "might" 

lol 

Eric PARKINSON words 

Stick to dress up time 👗 
HHSE
PonkenPlonken PonkenPlonken 32 minutes ago
@tbonaces80 @Princess17
What do you two think about this?
150 million pp says massively misunderstood story? 140mn historical volume too...
RAPT
theorysuit theorysuit 34 minutes ago
Damn, you got a hell a lot of these Paid Ihub accounts. Did you get a discount deal? This is the only social media platform that gets retails attention on this Sht ticker so i guess it is money well spent.

No paid pumpers? Go check the expenses on NWBO, they have several paid pro
NWBO
Hosai Hosai 35 minutes ago
Admittedly there could be a slight bias in that most applicants apply to FDA first which may mean if rejected less likely to then apply to EMA.
AVXL
ignatiusrielly35 ignatiusrielly35 35 minutes ago
Yes, but ultimately it is just supply/demand. 
AVXL
bradford86 bradford86 35 minutes ago
after the supreme court ruled --- misinterpreting the law --- and the 2019 retention of earnings --- the only outcome was recap and release --- and i had to quit my job w-2 to roll my 401k into this as well as then started doing contract work to buy more pre-tax--- working harder 2021-present than e
FNMA

Your Recent History

BOV
BONY34
Bny Mellon DRN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads